These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 24148617)
1. Liver environment and HCV replication affect human T-cell phenotype and expression of inhibitory receptors. Kroy DC; Ciuffreda D; Cooperrider JH; Tomlinson M; Hauck GD; Aneja J; Berger C; Wolski D; Carrington M; Wherry EJ; Chung RT; Tanabe KK; Elias N; Freeman GJ; de Kruyff RH; Misdraji J; Kim AY; Lauer GM Gastroenterology; 2014 Feb; 146(2):550-61. PubMed ID: 24148617 [TBL] [Abstract][Full Text] [Related]
2. Expression of programmed cell death protein 1 and T-cell immunoglobulin- and mucin-domain-containing molecule-3 on peripheral blood CD4+CD8+ double positive T cells in patients with chronic hepatitis C virus infection and in subjects who spontaneously cleared the virus. Caraballo Cortés K; Osuch S; Perlejewski K; Pawełczyk A; Kaźmierczak J; Janiak M; Jabłońska J; Nazzal K; Stelmaszczyk-Emmel A; Berak H; Bukowska-Ośko I; Paciorek M; Laskus T; Radkowski M J Viral Hepat; 2019 Aug; 26(8):942-950. PubMed ID: 30972915 [TBL] [Abstract][Full Text] [Related]
3. Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization. Nakamoto N; Kaplan DE; Coleclough J; Li Y; Valiga ME; Kaminski M; Shaked A; Olthoff K; Gostick E; Price DA; Freeman GJ; Wherry EJ; Chang KM Gastroenterology; 2008 Jun; 134(7):1927-37, 1937.e1-2. PubMed ID: 18549878 [TBL] [Abstract][Full Text] [Related]
4. Peripheral PD-1 Romani S; Stafford K; Nelson A; Bagchi S; Kottilil S; Poonia B Front Immunol; 2019; 10():1470. PubMed ID: 31316516 [TBL] [Abstract][Full Text] [Related]
5. HCV-specific T cells in HCV/HIV co-infection show elevated frequencies of dual Tim-3/PD-1 expression that correlate with liver disease progression. Vali B; Jones RB; Sakhdari A; Sheth PM; Clayton K; Yue FY; Gyenes G; Wong D; Klein MB; Saeed S; Benko E; Kovacs C; Kaul R; Ostrowski MA Eur J Immunol; 2010 Sep; 40(9):2493-505. PubMed ID: 20623550 [TBL] [Abstract][Full Text] [Related]
6. Lymphocyte activation gene 3 negatively regulates the function of intrahepatic hepatitis C virus-specific CD8+ T cells. Chen N; Liu Y; Guo Y; Chen Y; Liu X; Liu M J Gastroenterol Hepatol; 2015 Dec; 30(12):1788-95. PubMed ID: 26095288 [TBL] [Abstract][Full Text] [Related]
7. Coexpression of PD-1, 2B4, CD160 and KLRG1 on exhausted HCV-specific CD8+ T cells is linked to antigen recognition and T cell differentiation. Bengsch B; Seigel B; Ruhl M; Timm J; Kuntz M; Blum HE; Pircher H; Thimme R PLoS Pathog; 2010 Jun; 6(6):e1000947. PubMed ID: 20548953 [TBL] [Abstract][Full Text] [Related]
8. Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1/CTLA-4 blockade. Nakamoto N; Cho H; Shaked A; Olthoff K; Valiga ME; Kaminski M; Gostick E; Price DA; Freeman GJ; Wherry EJ; Chang KM PLoS Pathog; 2009 Feb; 5(2):e1000313. PubMed ID: 19247441 [TBL] [Abstract][Full Text] [Related]
9. Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity. McMahan RH; Golden-Mason L; Nishimura MI; McMahon BJ; Kemper M; Allen TM; Gretch DR; Rosen HR J Clin Invest; 2010 Dec; 120(12):4546-57. PubMed ID: 21084749 [TBL] [Abstract][Full Text] [Related]
10. Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression. Radziewicz H; Ibegbu CC; Fernandez ML; Workowski KA; Obideen K; Wehbi M; Hanson HL; Steinberg JP; Masopust D; Wherry EJ; Altman JD; Rouse BT; Freeman GJ; Ahmed R; Grakoui A J Virol; 2007 Mar; 81(6):2545-53. PubMed ID: 17182670 [TBL] [Abstract][Full Text] [Related]
11. A heterogeneous hierarchy of co-regulatory receptors regulates exhaustion of HCV-specific CD8 T cells in patients with chronic hepatitis C. Owusu Sekyere S; Suneetha PV; Kraft AR; Zhang S; Dietz J; Sarrazin C; Manns MP; Schlaphoff V; Cornberg M; Wedemeyer H J Hepatol; 2015 Jan; 62(1):31-40. PubMed ID: 25131771 [TBL] [Abstract][Full Text] [Related]
12. Peripheral loss of CD8(+) CD161(++) TCRVα7·2(+) mucosal-associated invariant T cells in chronic hepatitis C virus-infected patients. Barathan M; Mohamed R; Vadivelu J; Chang LY; Saeidi A; Yong YK; Ravishankar Ram M; Gopal K; Velu V; Larsson M; Shankar EM Eur J Clin Invest; 2016 Feb; 46(2):170-80. PubMed ID: 26681320 [TBL] [Abstract][Full Text] [Related]
13. Upregulation of PD-1 expression on circulating and intrahepatic hepatitis C virus-specific CD8+ T cells associated with reversible immune dysfunction. Golden-Mason L; Palmer B; Klarquist J; Mengshol JA; Castelblanco N; Rosen HR J Virol; 2007 Sep; 81(17):9249-58. PubMed ID: 17567698 [TBL] [Abstract][Full Text] [Related]
14. CD4+ and CD8+ T Cell Activation in Children with Hepatitis C. Sheiko MA; Golden-Mason L; Giugliano S; Hurtado CW; Mack CL; Narkewicz MR; Rosen HR J Pediatr; 2016 Mar; 170():142-8.e1. PubMed ID: 26743497 [TBL] [Abstract][Full Text] [Related]
15. CD160-associated CD8 T-cell functional impairment is independent of PD-1 expression. Viganò S; Banga R; Bellanger F; Pellaton C; Farina A; Comte D; Harari A; Perreau M PLoS Pathog; 2014 Sep; 10(9):e1004380. PubMed ID: 25255144 [TBL] [Abstract][Full Text] [Related]
16. CD8 Osuch S; Laskus T; Perlejewski K; Berak H; Bukowska-Ośko I; Pollak A; Zielenkiewicz M; Radkowski M; Caraballo Cortés K Front Immunol; 2022; 13():832206. PubMed ID: 35386708 [TBL] [Abstract][Full Text] [Related]
17. According to Hepatitis C Virus (HCV) Infection Stage, Interleukin-7 Plus 4-1BB Triggering Alone or Combined with PD-1 Blockade Increases TRAF1 Moreno-Cubero E; Subirá D; Sanz-de-Villalobos E; Parra-Cid T; Madejón A; Miquel J; Olveira A; González-Praetorius A; García-Samaniego J; Larrubia JR J Virol; 2018 Jan; 92(2):. PubMed ID: 29093082 [TBL] [Abstract][Full Text] [Related]
18. Dual function of the NK cell receptor 2B4 (CD244) in the regulation of HCV-specific CD8+ T cells. Schlaphoff V; Lunemann S; Suneetha PV; Jaroszewicz J; Grabowski J; Dietz J; Helfritz F; Bektas H; Sarrazin C; Manns MP; Cornberg M; Wedemeyer H PLoS Pathog; 2011 May; 7(5):e1002045. PubMed ID: 21625589 [TBL] [Abstract][Full Text] [Related]
19. Inhibitory molecules that regulate expansion and restoration of HCV-specific CD4+ T cells in patients with chronic infection. Raziorrouh B; Ulsenheimer A; Schraut W; Heeg M; Kurktschiev P; Zachoval R; Jung MC; Thimme R; Neumann-Haefelin C; Horster S; Wächtler M; Spannagl M; Haas J; Diepolder HM; Grüner NH Gastroenterology; 2011 Oct; 141(4):1422-31, 1431.e1-6. PubMed ID: 21763239 [TBL] [Abstract][Full Text] [Related]
20. Characteristics of splenic CD8+ T cell exhaustion in patients with hepatitis C. Sumida K; Shimoda S; Iwasaka S; Hisamoto S; Kawanaka H; Akahoshi T; Ikegami T; Shirabe K; Shimono N; Maehara Y; Selmi C; Gershwin ME; Akashi K Clin Exp Immunol; 2013 Oct; 174(1):172-8. PubMed ID: 23773130 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]